New NCI Award Recognizes the Importance of Scientific Community
In the lab of Minna Roh-Johnson, PhD, great science and great mentorship are inseparable. Now, a new National Cancer Institute (NCI) award has made that philosophy concrete. The award is is an admini…
Nina Bhardwaj, MD, PhD, Ward-Coleman Chair in Cancer Research and director of the Vaccine and Cell Therapy Laboratory at the Icahn School of Medicine at Mount Sinai, has been elected to the National …
Editor-in-Chief of Journal of the American College of Surgeons Appointed
Thomas Varghese Jr., MD, MS, MBA, FACS, has been named the new editor-in-chief of the Journal of the American College of Surgeons, effective March 1, 2025. Dr. Varghese currently serves as associate …
Richard J. Bleicher, MD, FACS, chief of the Division of Breast Surgery and clinical director of the Breast Service Line at Fox Chase Cancer Center, has been appointed vice chair of the National Accre…
Maihle Receives Mayo Clinic Distinguished Alumni Award
Nita Maihle, PhD, has won a Mayo Clinic Distinguished Alumni Award. Dr. Maihle is a professor of medicine at the University of Mississippi Medical Center (UMMC). She is a pioneer in the field of tran…
A team of lung cancer specialists from Fox Chase Cancer Center and Temple Health was recently recognized by the International Association for the Study of Lung Cancer (IASLC) as the winner of the Nor…
The University of New Mexico Comprehensive Cancer Center has successfully received reaccreditation from the Commission on Cancer (CoC), a quality program of the American College of Surgeons. The CoC …
Roswell Park Comprehensive Cancer Center’s Intensive Care Unit has earned the Beacon Award for Excellence from the American Association of Critical-Care Nurses. The bronze award marks the cancer cent…
The Thyroid and Thyroid Cancer Research team, or ThyCARE, at the Rogel Cancer Center received the inaugural Endocrine Care Innovation Award from the American Association of Endocrinology.
AACI mourns the loss of Ken Cowan, MD, PhD, who passed away on Sunday, December 15. A former member of AACI’s Board of Directors, Dr. Cowan led the NCI-Designated Cancer Center at the University of N…
Stand Up for Science Rallies Set for March 7 Nationwide
Stand Up for Science is supporting rallies in Washington, DC, and 31 other U.S. cities on Friday, March 7. The grassroots group aims to defend science as a public good and a pillar of social, politic…
Register Today for the 17th Annual AACICRI Meeting
Registration is open for the 17th Annual AACI Clinical Research Innovation (CRI) Meeting, June 23-25 at the Loews Chicago O'Hare Hotel in Rosemont, IL. A discounted early registration rate will be av…
The GVHD Alliance has honored Shernan Holtan, MD, chief of blood and marrow transplantation at Roswell Park Comprehensive Cancer Center, as the recipient of the 2025 Lukas D. Wartman Award. This reco…
Postdoctoral Associate Selected as Forbeck Scholar
Emma Guilbaud, PhD, a postdoctoral associate at Fox Chase Cancer Center, has been selected as a Forbeck Scholar by the William Guy Forbeck Research Foundation. This appointment recognizes early caree…
Ze’ev Ronai, PhD, director of the Translational Research Institute at Cedars-Sinai, has received an Outstanding Investigator Award from the National Cancer Institute. The award comes with approximate…
Federal Funding Received to Integrate Clinical Research Into Primary Care Practices
With $1.2 million in initial funding, University of Oklahoma Health Sciences researchers will help the National Institutes of Health build a nationwide infrastructure that ultimately will improve acc…
Federal Program Expands Treatment to Rural and Frontier Communities
Huntsman Cancer Institute (HCI) at the University of Utah has received a federal contract award that will broaden access to specialized cancer care for Utah’s rural and frontier patients. The five-ye…
Chang to Lead Houston Methodist Academic Institute
Jenny Chang, MD, MBBChir, MHCM, has been chosen to lead the Houston Methodist Academic Institute. Dr. Chang has led the Dr. Mary and Ron Neal Cancer Center since 2010. Nestor F. Esnaola, MD, MPH, MBA…
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel Can…
Many Medicare patients with advanced cancer receive potentially aggressive treatment at the expense of supportive care, according to an analysis of Medicare records. The study examined the quality of…
An international team of doctors led by Joshua Brody, MD, director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai, has made a major breakthrough in treating a comm…
At the 25th annual Meeting of the Society of Urologic Oncology, Daniel J. George, MD, presented a session on real-world treatment and clinical outcomes for patients with metastatic castration-resista…
Stanford researchers have conducted the first large-scale screen of single nucleotide variants, homing in on fewer than 400 that are essential to initiate and drive cancer growth. These variants cont…
University of New Mexico Comprehensive Cancer Center
Like a football team disrupting the opponent’s play, researchers at UNM Comprehensive Cancer Center are designing a gel to prevent cancers caused by human papillomaviruses (HPVs). With no other antiv…
Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML). New …
A new UK Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by establishing a five-month progression-free survival benchmark for ev…
Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, accord…
UCSF Helen Diller Family Comprehensive Cancer Center
Researchers at UC San Francisco have found that some cancers, like glioma, make unique, jumbled proteins that make them stand out. These newly recognized cancer-specific proteins, or antigens, could …
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic resistance to common breast cancer drugs – including a class of targeted tre…
Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine
An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent the longest reported remission to date in a patient treated with chimeric…
Emory University chemists invented a reaction to streamline the total synthesis of a compound, phaeocaulisin A, extracted from a plant used in traditional Chinese medicine. In laboratory dish experim…
Huntsman Cancer Institute at the University of Utah
In a randomized clinical trial, researchers from Huntsman Cancer Institute have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had similar effectiveness to more fre…
Fox Chase Cancer Center researchers, with colleagues from Moffitt Cancer Center, recently published an updated review of guidelines governing the use of neoadjuvant and adjuvant therapy for patients …
In two studies, University of Michigan researchers are the first to demonstrate in the U.S. that self-sampling is just as effective as speculum-based testing for human papillomavirus (HPV) detection.
By characterizing the demographics and comorbidities of patients screened for lung cancer in three states, a new study led by the UF Health Cancer Center lays the groundwork for a personalized approa…
A team of scientists at The University of Kansas Cancer Center’s Cancer Biology research program are exploring ways to improve the CA125 blood test, one of the primary tools for detecting ovarian can…
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
A team of researchers from the University of Maryland School of Medicine and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center have analyzed the pre-treatment CT s…
In patients with high-risk HER2-positive breast cancer, postsurgery, or adjuvant, treatment with trastuzumab emtansine reduced the long-term risk of death or invasive disease by 46 percent and improv…
Comprehensive Cancer Center St. Jude Children’s Research Hospital
Through the Global Platform for Access to Childhood Cancer Medicines, the World Health Organization (WHO) and St. Jude have begun distributing critically-needed childhood cancer medicines in two of s…
Season 9 of the Patient Advocate Foundation's (PAF) acclaimed podcast, Advocates in Action, is now streaming. Please listen to the first episode, featuring PAF's Gwen Darien in conversation with Fred…
OU Health Stephenson Cancer Center has launched a mobile lung cancer screening bus, in collaboration with the Tobacco Settlement Endowment Trust and others, to bring critical early detection capabili…
At Markey Cancer Center, we’re breaking down barriers to advance innovations in cancer research on a global scale. Read the full story at ukhealthcare.com/cancer.
Theodorescu Appointed Director of the University of Arizona Cancer Center
Dan Theodorescu, MD, PhD, has been appointed director of the University of Arizona Cancer Center. Dr. Theodorescu is a leader in bladder cancer research. He has also served as director of Cedars-Sina…
Site neutrality is a defined policy in which Medicare Part B would pay hospital outpatient departments (HOPDs) and physician-based practices the same amount if they provided the same service. While i…
Talking Points on Facilities & Administration (F&A)/Indirect Costs
F&A (Facilities & Administrative) costs—also known as indirect costs—support critical research infrastructure, including utilities, maintenance, lab equipment, compliance, and security.
